综合老年评估对老年癌症患者短期死亡率的影响——一项随访研究
本研究纳入70岁及以上转诊至奥胡斯大学医院肿瘤科、拟接受头颈癌、肺癌、上消化道癌或结直肠癌治疗的老年患者,评估与干预联动的综合老年评估(CGA)对90天死亡率的影响。2016年1月1日至2018年7月31日共识别781例患者,407例接受CGA、307例未接受;CGA组90天内死亡68例(17%),非CGA组死亡74例(24%),粗OR为0.63(95%CI 0.43;0.91),校正OR为0.62(95%CI 0.39;1.00)。作者认为与肿瘤评估联动的CGA可能降低转诊接受肿瘤治疗的老年癌症患者的短期死亡率。
要点
- CGA组90天内死亡68例(17%),非CGA组死亡74例(24%)。
- 粗OR为0.63(95%CI 0.43;0.91),p=0.014。
- 校正OR为0.62(95%CI 0.39;1.00),p=0.05。
核心结论
- 与肿瘤评估联动的CGA可能降低转诊接受肿瘤治疗的老年癌症患者的短期死亡率。
研究设计与样本
- 研究纳入70岁及以上、转诊至奥胡斯大学医院肿瘤科拟接受头颈癌、肺癌、上消化道癌或结直肠癌治疗的患者,所有患者均被邀请接受CGA。
- 2016年1月1日至2018年7月31日共识别781例患者,排除67例;中位年龄76岁(四分位距72-80岁)。
- 407例接受CGA,307例未接受CGA;CGA评估合并症、自主性、心理、认知、营养状态和用药六个领域,发现缺陷即提出干预。
- 随访在纳入后90天进行。
主要发现
- 原发肿瘤部位分布为头颈癌5%、肺癌46%、上消化道癌20%、结直肠癌29%。
- CGA组中325例(80%)被提出老年干预,319例(78%)启动干预。
- 90天内共142例(20%)死亡;非CGA组死亡74例(24%),CGA组死亡68例(17%)。
- CGA组死亡粗OR为0.63(95%CI 0.43;0.91),p=0.014;校正OR为0.62(95%CI 0.39;1.00),p=0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate the impact of comprehensive geriatric assessment (CGA) linked to intervention on identified problems on 90-day mortality in older patients with cancer. PATIENTS AND METHODS: Eligible patients were 70 years or older and referred to the Oncology Department at Aarhus University Hospital in order to receive treatment for head and neck cancer (HNC), lung cancer (LC), upper gastrointestinal tract (UGI) cancer or colorectal cancer (CRC). All patients were intendedly invited for CGA. Patients for the study were identified by the oncology department. CGA evaluated six domains: comorbidity, autonomy, mental, cognitive, nutritional status and medication. Intervention was proposed if deficits were detected. Follow-up was performed 90 days after inclusion. RESULTS: From January 1st 2016 through July 31st 2018, 781 patients were identified. Sixty-seven patients were excluded. Median age: 76 (interquartile range: 72-80) years. Primary tumour sites: 5% HNC, 46% LC, 20% UGI and 29% CRC. A total of 407 patients had CGA, 307 had no CGA. Geriatric intervention was proposed in 325 patients (80%) and initiated in 319 patients (78%) in the CGA group. Within 90 days, 142 patients (20%) died. In the non-CGA group, 74 patients died (24%), versus 68 patients (17%) in the CGA group. A potential reduction of death in the CGA group was detected: crude odds ratio (OR): 0.63 (95% confidence interval: 0.43; 0.91), p = 0.014. Adjusted OR: 0.62 (95% confidence interval: 0.39; 1.00), p = 0.05. CONCLUSION: A CGA linked to oncology evaluation may reduce short-term mortality in older patients with cancer referred for oncological treatment.
引用
- Ørum M, Jensen K, Gregersen M, et al. Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer-a follow-up study. Eur J Cancer. 2019. PMID: 31163339. doi:10.1016/j.ejca.2019.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。